Glycine involvement in DDT-induced myoclonus

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• DDT (dichlorodiphenyltrichloroethane) exposure in rats induces a syndrome characterized by tremor, myoclonus, seizures, hyperthermia, and behavioral changes.
• The precise neurochemical mechanisms underlying DDT-induced myoclonus remain incompletely understood, necessitating further investigation into neurotransmitter systems.

Purpose of the Study:

• To investigate the role of the glycinergic system in the manifestation of DDT-induced myoclonus in a rat model.
• To determine the effects of glycine and its prodrug, milacemide, on DDT-induced neurological symptoms, particularly myoclonus.

Main Methods:

• Rats were exposed to DDT to induce the characteristic syndrome.
• Whole-brain and regional glycine levels were measured using biochemical assays.
• The effects of intraventricular glycine administration and intraperitoneal milacemide administration on DDT-induced myoclonus were evaluated.

Main Results:

• DDT exposure did not alter whole-brain glycine levels during various stages of myoclonus or seizures.
• Regional analysis revealed transient decreases in pons and medulla glycine levels, followed by increases despite worsening myoclonus.
• Both intraventricular glycine and intraperitoneal milacemide effectively suppressed DDT-induced myoclonus, with milacemide significantly increasing glycine levels across multiple brain regions, especially forebrain structures.

Conclusions:

• The glycinergic system plays a significant role in the pathophysiology of DDT-induced myoclonus.
• Enhancing central nervous system glycine levels, particularly in forebrain regions, can ameliorate DDT-induced myoclonus.
• These findings suggest potential therapeutic strategies targeting the glycinergic system for managing certain neurotoxic effects.